arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MeiraGTx Holdings plc

MGTX
$11.74 ▼ -0.63 (-5.13%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

MeiraGTx Holdings plc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $944.3M
Dividend Yield —
Revenue Growth 144.6% ↗
Op. Margin -130.2% ↗
ROIC 1829.2% ↗
FCF / Share $-0.62 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$81.39M
↑ +144.6% —
Net Income Profit after all expenses
$-114.20M
↑ +22.7% —
Operating Margin Operating profit as % of sales
-130.2%
↑ +73.6% 1th
FCF / Share Free cash flow per share
$-0.62
↑ +60.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
2
Financial Health ↑
32
Cash Quality ↓
37

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 38 quarters